Sale!

MET Amplification Testing for Non-Small Cell Lung Cancer (NSCLC)

Original price was: R4,000.Current price is: R3,000.

-25%

Facing a lung cancer diagnosis can be overwhelming, but understanding your specific cancer type is the first step toward effective treatment. Our MET Amplification test for Non-Small Cell Lung Cancer (NSCLC) provides crucial information about your cancer’s genetic makeup. This specialised test helps identify whether your cancer has MET gene amplification, which can guide your oncologist toward targeted therapies that may be more effective than traditional treatments. For only ZAR 3,000 (regularly ZAR 4,000), you gain access to precise genetic information that could significantly impact your treatment journey. Our advanced FISH technology ensures accurate results within 7-8 days, giving you and your healthcare team the clarity needed to make informed decisions. With nationwide coverage including Johannesburg, Cape Town, and Durban, we’re here to support South African patients with reliable, compassionate cancer testing services.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

MET Amplification Test for NSCLC | ZAR 3
MET Amplification Testing for Non-Small Cell Lung Cancer (NSCLC)
R4,000 Original price was: R4,000.R3,000Current price is: R3,000.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Understanding Your Lung Cancer: MET Amplification Testing

Receiving a lung cancer diagnosis can feel overwhelming, but knowing the specific genetic characteristics of your cancer empowers you and your medical team to choose the most effective treatment path. Our MET Amplification test for Non-Small Cell Lung Cancer provides the critical genetic information needed for personalised cancer care.

What is MET Amplification Testing?

MET Amplification testing examines whether your lung cancer cells have extra copies of the MET gene. When this gene is amplified (has too many copies), it can drive cancer growth and progression. Identifying this genetic alteration helps your oncologist determine if targeted therapies specifically designed for MET-amplified cancers could benefit you.

Using advanced FISH (Fluorescence In Situ Hybridisation) technology, we analyse your tumour tissue with exceptional accuracy, providing reliable results that form the foundation of your treatment strategy.

Who Should Consider This Test?

This test is particularly important for patients who:

  • Have been diagnosed with Non-Small Cell Lung Cancer (NSCLC)
  • Are exploring targeted therapy options beyond standard chemotherapy
  • Have cancer that has progressed despite initial treatment
  • Want to understand all available treatment possibilities
  • Are working with their oncologist to develop a personalised treatment plan

Early genetic testing can open doors to treatment options you might not have considered, giving you more control over your cancer journey.

Why This Test Matters for Your Health

Knowing your MET amplification status provides several crucial benefits:

  • Targeted Treatment Options: Identifies if you may benefit from MET-specific inhibitors
  • Personalised Care: Helps your medical team tailor treatment to your cancer’s genetic profile
  • Informed Decisions: Provides clarity for you and your family when considering treatment paths
  • Potential for Better Outcomes: Targeted therapies often have different side effect profiles and may be more effective
  • Peace of Mind: Knowing you’ve explored all genetic testing options for comprehensive care

Understanding Your Results

Your results will clearly indicate whether MET amplification is present in your cancer cells. Our comprehensive report includes:

  • Clear positive or negative result for MET amplification
  • Detailed explanation in easy-to-understand language
  • Interpretation guidance for your healthcare provider
  • Next steps and questions to discuss with your oncologist

Remember: Your oncologist will review these results with you and explain how they impact your treatment options. We’re here to provide the accurate information your medical team needs.

Affordable, Life-Changing Information

Test Description Regular Price Special Price Turnaround Time
MET Amplification (NSCLC) Test ZAR 4,000 ZAR 3,000 7-8 days

This investment in your health could lead to more effective treatment choices and potentially better outcomes – making it invaluable for your cancer journey.

Why Trust Oracle Genomics?

  • Nationwide Coverage: Serving patients across South Africa including Johannesburg, Cape Town, Durban, and Pretoria
  • Medical Expertise: Working closely with South Africa’s leading oncologists and healthcare providers
  • Advanced Technology: Using gold-standard FISH methodology for accurate genetic analysis
  • Rapid Results: 7-8 day turnaround means faster treatment decisions
  • Patient-Focused: Compassionate support throughout your testing journey

Test Requirements

  • Sample Type: Paraffin embedded tissue blocks from your tumour biopsy
  • Prescription: Requires a doctor’s prescription (not applicable for surgery, pregnancy, or travel abroad cases)
  • Method: FISH (Fluorescence In Situ Hybridisation)

Your healthcare provider will coordinate sample collection and ensure proper handling for accurate results.

Take Control of Your Cancer Journey Today

Don’t leave treatment options unexplored. Early genetic testing could reveal targeted therapy possibilities that might be more effective for your specific cancer type.

Book your MET Amplification test now and take the first step toward personalised cancer care.

Contact your healthcare provider to discuss this test, or reach out to us for more information about how genetic testing can inform your treatment decisions.

Your genetic information could be the key to more effective treatment – act now while this special pricing is available.